sodium lauryldiaminoethylglycine

Sodium lauryldiaminoethylglycine is an amphoteric surfactant utilized as an antiseptic and disinfectant, primarily developed by Saraya Co., Ltd. It is commonly formulated in gargle solutions and mouthwashes to reduce the microbial load in the oral cavity. The compound functions through the non-specific disruption of lipid bilayers, which leads to the inactivation of enveloped viruses and the lysis of bacterial cell membranes. During the COVID-19 pandemic, sodium lauryldiaminoethylglycine was investigated in clinical trials for its potential to reduce the viral load of SARS-CoV-2 in the saliva of asymptomatic or mildly symptomatic patients, thereby aiming to mitigate viral shedding and transmission.

Brand names

Cololo

Other names

sodium lauryl diaminoethyl glycinesodium N-lauryl-N'-(2-aminoethyl)glycinate